Concepedia

Arthur D. Weissman

AD

Statistics

Publications

15

Citations

1.2K

H-Index

12

Active since

1980

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

Arthur D. Weissman is an author at National Institute on Drug Abuse specializing in medicine, neuropharmacology, and pharmacology.

Publications per year

1980–2011

15

Publications

15

Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.

B. Kenneth Koe, Arthur D. Weissman, W. M. WELCH et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 258 citations · Full text

, , +9

Sigma receptors in post-mortem human brains.

Arthur D. Weissman, Tung‐Ping Su, John C. Hedreen et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 169 citations

, , +12

Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia

Arthur D. Weissman, Manuel F. Casanova, Joel E. Kleinman et al. · Biological Psychiatry · 1991 · 150 citations

, , +8

Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets

Thomas B. Knudsen, Keith A. Houck, Nisha S. Sipes et al. · Toxicology · 2011 · 136 citations

, , +8

Endogenous ligands for sigma opioid receptors in the brain (“sigmaphin”): Evidence from binding assays

Tsung‐Ping Su, Arthur D. Weissman, S.Y. Yeh · Life Sciences · 1986 · 118 citations

, , +14

1–5 of 15